Nachrichten zur Biophytis Co. Aktie

Form 6-K Biophytis SA For: Aug 25

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Biophytis Announces Next Regulatory Steps in Europe and the United States for its COVA Project

PARIS FRANCE and CAMBRIDGE, MA / ACCESSWIRE / August 16, 2023 / Biophytis SA (Nasdaq CM:BPTS, Euronext Growth Paris:ALBPS), ("Biophytis"),…

Biophytis Receives a Positive Opinion for its SARA-31 Phase 3 Study in Sarcopenia in Europe

PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / August 8, 2023 / Biophytis SA (Nasdaq CM:BPTS, Euronext Growth Paris:ALBPS), ("Biophytis"),…

Form 6-K Biophytis SA For: Jul 21

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Biophytis Shares Drop 11% After Request for Meeting With FDA on Covid-19 Treatment

Biophytis Shares Drop 11% After Request for Meeting With FDA on Covid-19 Treatment...…

Biophytis has Requested a Pre-Submission Meeting with the FDA for an Emergency Use Authorization of Sarconeos for the Treatment of COVID-19

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / July 20, 2023 / Biophytis SA (Nasdaq CM:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis"), a…

Biophytis Shares Drop 12% on Direct Offering Pricing

Biophytis Shares Drop 12% on Direct Offering Pricing...…

Form 6-K Biophytis SA For: Jul 19

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Biophytis down 12% on $3.8M offering

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Biophytis Announces $3.8 Million Registered Direct Offering

PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / July 19, 2023 / Biophytis SA (Nasdaq CM:BPTS, Euronext Growth Paris:ALBPS), ("Biophytis"…

Biophytis Shares Rise 28% After Partnership to Produce Neuromuscular Disease Treatment Sarconeos

Biophytis Shares Rise 28% After Partnership to Produce Neuromuscular Disease Treatment Sarconeos...…

iCAD, Biophytis top healthcare gainers; Lixte, Masimo lead losers pack

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 6-K Biophytis SA For: Jul 18

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket

Gainers Biophytis S.A. (NASDAQ: BPTS) shares surged 53.9% to $3.31 in pre-market trading after the company signed a partnership with SEQENS…

Biophytis and SEQENS will together produce Sarconeos active compound

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Biophytis and SEQENS Sign a Partnership to Produce Sarconeos Active Compound

PARIS, FRANCE / ACCESSWIRE / July 18, 2023 / Biophytis SA (Nasdaq CM:BPTS, Euronext Growth Paris:ALBPS), ("Biophytis"), a clinical-stage biotechnology…

Form 6-K Biophytis SA For: Jul 10

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Biophytis Has Filed with The FDA For Authorization to Initiate SARA-31 Phase 3 Study in Sarcopenia

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / July 10, 2023 / Biophytis SA (Nasdaq CM:BPTS)(Euronext Growth Paris:ALBPS) (the "Company"…

Form 6-K Biophytis SA For: Jun 20

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Biophytis Reports Clinical Results for Sarconeos in Sarcopenia Treatment at the 16th SCWD International Congress

PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / June 19, 2023 / Biophytis SA (Nasdaq CM: BPTS, Euronext Growth Paris:…

Biophytis: Results of the Annual General Meeting on June 16, 2023 All Resolutions Presented by the Company Have Been Adopted

RESULTS OF THE ANNUAL GENERAL MEETING ON JUNE 16, 2023ALL RESOLUTIONS PRESENTED BY THE COMPANY HAVE BEEN ADOPTEDPARIS FRANCE and…

Form 6-K Biophytis SA For: Jun 05

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Biophytis to Participate at the BIO International Convention in Boston from the 5th to the 8th of June

PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / June 5, 2023 / Biophytis SA (NasdaqCM:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the…

Form 6-K Biophytis SA For: May 26

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Biophytis seeks early access authorization of COVID drug Sarconeos in France

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Biophytis has Filed with the French National Authority for Health an Application for Early Access Authorisation for Sarconeos in the Treatment of Severe Forms of COVID-19

PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / May 26, 2023 / Biophytis SA (NasdaqCM:BPTS)(Euronext Growth Paris:ALBPS) (the "Company" or…

Form 6-K Biophytis SA For: May 25

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Biophytis ticks higher after presenting COVID drug data at conference

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Biophytis Presented Positive Results of Phase 2-3 COVA Study At The American Thoracic Society International Conference

PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / May 25, 2023 / Biophytis SA (NasdaqCM:BPTS)(Euronext Growth Paris:ALBPS) (the "Company" or…

Form 6-K Biophytis SA For: May 15

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Biophytis has Filed with the EMA for Authorization to Initiate SARA-31 Phase 3 Study in Sarcopenia

PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / May 15, 2023 / Biophytis SA (NasdaqCM:BPTS)(Euronext Growth Paris:ALBPS) (the "Company" or…

Successful Capital Increase for Biophytis with €2.3 million Raised

Success of the placement with professional investors, historical supporters of the Company, for an amount of €1.9M.Strong participation of retail…

Biophytis Launches a Round of Fundraising for Approximately 2 Million Euros

Capital increases as part of a global offering comprising an offer reserved for professional investors and a public offering for…

Form 6-K Biophytis SA For: May 09

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Biophytis seeks EMA meeting to discuss prefiling for oral COVID drug Sarconeos

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Biophytis has Requested a Pre-Submission Meeting with the EMA for the Marketing Authorisation of Sarconeos for the Treatment of COVID-19

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / May 9, 2023 / Biophytis SA (NasdaqCM:BPTS)(Euronext Growth Paris:ALBPS) (the "Company" or…

Biophytis: Biophytis Presented Sarconeos As A Possible Treatment Candidate for Long COVID After Hospitalization During The 13th Annual International Conference on Frailty and Sarcopenia Resea

Biophytis presented Sarconeos (BIO101) as a possible treatment candidate for long COVID after hospitalization during the 13th annual International Conference…

Form 6-K Biophytis SA For: Mar 21

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

dpa-AFX ProFeed